This upregulation endows Fibulin-3 with new functions as an autocrine/paracrine activator of Notch and NF-κB signaling pathways, consequently amplifying GBM invasion, vascularization, and the survival of tumor-initiating cell populations. This evidence concerns the gene EFEMP1 and glioblastoma.